Evidence map›Paper›PMID 36505645›Full record

ArticleJournal of family medicine and primary care2022

Picking up an insulinoma - The challenges ahead.

Ashok Sunder, Sudip Saha, Bhagyalakshmi Satyanarayan, Manish Kumar, Nilanjan Sarkar

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ashok SunderDepartment of General Medicine, Tata Main Hospital, Tata Steel, Jamshedpur, Jharkhand, India.
Sudip SahaDepartment of General Medicine, Tata Main Hospital, Tata Steel, Jamshedpur, Jharkhand, India.
Bhagyalakshmi SatyanarayanDepartment of General Medicine, Tata Main Hospital, Tata Steel, Jamshedpur, Jharkhand, India.
Manish KumarDepartment of General Medicine, Tata Main Hospital, Tata Steel, Jamshedpur, Jharkhand, India.
Nilanjan SarkarDepartment of General Medicine, Tata Main Hospital, Tata Steel, Jamshedpur, Jharkhand, India.
Tata Steel (India) · INTata Main Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulinoma is a rare pancreatic neuroendocrine tumour (PNET) with an incidence rate of 4 per million population, and the most common cause of hypoglycaemia due to endogenous hyperinsulinism. We present the story of a 61-year-old male, who was extensively evaluated at many hospitals for his symptoms of giddiness, uneasiness and recurrent black outs for the last 3 months, his symptoms disappearing with a carbohydrate rich meal or sweets. Random sugar and fasting sugar values noted were low, with elevated insulin and C-peptide levels. Diagnosis of insulinoma was confirmed by a DOTA PET scan involving the tail of the pancreas and then surgically removed. Early detection is crucial for early surgery to allay symptoms. We describe our diagnostic and treatment plan with reference to previously published reports.

Indexed as

DOTA PET scangastrinomainsulinomamultiple endocrine neoplasiapancreatic neuroendocrine tumours

Identifiers

PMID36505645
PMCPMC9731071
OpenAlexW4311280109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.